Literature DB >> 31839966

Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug.

Josbert J Keller1,2, Maria Jgt Vehreschild3, Christian L Hvas4, Simon Md Jørgensen4, Jouzas Kupciskas5, Alexander Link6, Chris Jj Mulder7, Simon D Goldenberg8, Ramesh Arasaradnam9, Harry Sokol10,11,12, Antonio Gasbarrini13, Christoph Hoegenauer14, Elizabeth M Terveer15,2, Ed J Kuijper16,2, Perttu Arkkila17.   

Abstract

Mesh:

Year:  2019        PMID: 31839966      PMCID: PMC6894000          DOI: 10.1177/2050640619887579

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


× No keyword cloud information.
  13 in total

1.  European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection.

Authors:  S B Debast; M P Bauer; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2014-03       Impact factor: 8.067

2.  Ensuring the safe and effective FDA regulation of fecal microbiota transplantation.

Authors:  Rachel E Sachs; Carolyn A Edelstein
Journal:  J Law Biosci       Date:  2015-07-06

Review 3.  Clinical Application and Potential of Fecal Microbiota Transplantation.

Authors:  R E Ooijevaar; E M Terveer; H W Verspaget; E J Kuijper; J J Keller
Journal:  Annu Rev Med       Date:  2018-11-07       Impact factor: 13.739

4.  The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.

Authors:  Benjamin H Mullish; Mohammed Nabil Quraishi; Jonathan P Segal; Victoria L McCune; Melissa Baxter; Gemma L Marsden; David J Moore; Alaric Colville; Neeraj Bhala; Tariq H Iqbal; Christopher Settle; Graziella Kontkowski; Ailsa L Hart; Peter M Hawkey; Simon D Goldenberg; Horace R T Williams
Journal:  Gut       Date:  2018-08-28       Impact factor: 23.059

5.  OpenBiome remains open to serve the medical community.

Authors:  Mark Smith; Zain Kassam; Carolyn Edelstein; James Burgess; Eric Alm
Journal:  Nat Biotechnol       Date:  2014-09       Impact factor: 54.908

6.  A necessary discussion after transmission of multidrug-resistant organisms through faecal microbiota transplantations.

Authors:  Ed J Kuijper; Jessica Allegretii; Peter Hawkey; Harry Sokol; Simon Goldenberg; Gianluca Ianiro; Antonio Gasbarrini; Patrizia Kump; Samuel P Costello; Josbert Keller; Maria J G T Vehreschild
Journal:  Lancet Infect Dis       Date:  2019-11       Impact factor: 25.071

7.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

Authors:  L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

8.  Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660-A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection.

Authors:  Erik R Dubberke; Christine H Lee; Robert Orenstein; Sahil Khanna; Gail Hecht; Dale N Gerding
Journal:  Clin Infect Dis       Date:  2018-09-28       Impact factor: 9.079

Review 9.  How to: Establish and run a stool bank.

Authors:  E M Terveer; Y H van Beurden; A Goorhuis; J F M L Seegers; M P Bauer; E van Nood; M G W Dijkgraaf; C J J Mulder; C M J E Vandenbroucke-Grauls; H W Verspaget; J J Keller; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2017-05-19       Impact factor: 8.067

10.  Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection.

Authors:  Emilie Dehlholm-Lambertsen; Bianca K Hall; Simon M D Jørgensen; Christine W Jørgensen; Mia E Jensen; Sara Larsen; Josephine S Jensen; Lars Ehlers; Jens F Dahlerup; Christian L Hvas
Journal:  Therap Adv Gastroenterol       Date:  2019-04-10       Impact factor: 4.409

View more
  8 in total

1.  Faecal microbiota transplants: Why do we not consider them as Advanced Therapy Medicinal Products?

Authors:  Frederick Verbeke; Bart De Spiegeleer
Journal:  United European Gastroenterol J       Date:  2021-05-07       Impact factor: 4.623

2.  Towards an EU-wide suitable regulatory framework for faecally derived, industrially manufactured medicinal products.

Authors:  Tue Anker Mikkelsen; James Roger McIlroy; Madeleine Mimiague; Alice Rouanet; Luc Sterkman
Journal:  United European Gastroenterol J       Date:  2020-02-23       Impact factor: 4.623

3.  Stools' donor recruitment, a challenge in pandemic times.

Authors:  Maria Manuela Estevinho
Journal:  United European Gastroenterol J       Date:  2021-10-22       Impact factor: 4.623

Review 4.  Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant Recipients.

Authors:  Nirja Mehta; Tiffany Wang; Rachel J Friedman-Moraco; Cynthia Carpentieri; Aneesh K Mehta; Nadine Rouphael; Tanvi Dhere; Christian P Larsen; Colleen S Kraft; Michael H Woodworth
Journal:  J Clin Microbiol       Date:  2021-06-16       Impact factor: 11.677

5.  The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey.

Authors:  Simon Mark Dahl Baunwall; Elisabeth M Terveer; Jens Frederik Dahlerup; Christian Erikstrup; Perttu Arkkila; Maria Jgt Vehreschild; Gianluca Ianiro; Antonio Gasbarrini; Harry Sokol; Patrizia K Kump; Reetta Satokari; Danny De Looze; Séverine Vermeire; Radislav Nakov; Jan Brezina; Morten Helms; Jens Kjeldsen; Anne A Rode; Sabrina Just Kousgaard; Laurent Alric; Caroline Trang-Poisson; Julien Scanzi; Alexander Link; Andreas Stallmach; Juozas Kupcinskas; Peter Holger Johnsen; Kjetil Garborg; Eugenia Sánchez Rodríguez; Lena Serrander; Robert J Brummer; Katerina Tatiana Galpérine; Simon D Goldenberg; Benjamin H Mullish; Horace Rt Williams; Tariq H Iqbal; Cyriel Ponsioen; Ed J Kuijper; Giovanni Cammarota; Josbert J Keller; Christian Lodberg Hvas
Journal:  Lancet Reg Health Eur       Date:  2021-07-19

6.  The Regulatory Approach for Faecal Microbiota Transplantation as Treatment for Clostridioides difficile Infection in Italy.

Authors:  Maria Chiara de Stefano; Benedetta Mazzanti; Francesca Vespasiano; Letizia Lombardini; Massimo Cardillo
Journal:  Antibiotics (Basel)       Date:  2022-04-05

7.  Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century.

Authors:  Magdy El-Salhy; Tanisa Patcharatrakul; Sutep Gonlachanvit
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

8.  A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group.

Authors:  Josbert J Keller; Rogier E Ooijevaar; Christian L Hvas; Elisabeth M Terveer; Simone C Lieberknecht; Christoph Högenauer; Perttu Arkkila; Harry Sokol; Oleksiy Gridnyev; Francis Mégraud; Patrizia K Kump; Radislav Nakov; Simon D Goldenberg; Reetta Satokari; Sergiy Tkatch; Maurizio Sanguinetti; Giovanni Cammarota; Andrey Dorofeev; Olena Gubska; Gianluca Laniro; Eero Mattila; Ramesh P Arasaradnam; Shiv K Sarin; Ajit Sood; Lorenza Putignani; Laurent Alric; Simon M D Baunwall; Juozas Kupcinskas; Alexander Link; Abraham G Goorhuis; Hein W Verspaget; Cyriel Ponsioen; Georgina L Hold; Herbert Tilg; Zain Kassam; Ed J Kuijper; Antonio Gasbarrini; Chris J J Mulder; Horace R T Williams; Maria J G T Vehreschild
Journal:  United European Gastroenterol J       Date:  2021-03-09       Impact factor: 4.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.